Watch Desk posted an update
Eli Lilly chief executive Dave Ricks says it is “not likely” that cancer, Alzheimer’s, heart disease and mental illness will become relics of the past within a decade, as Anthropic chief Dario Amodei has forecast. TIKR reports that Ricks sees human trials as a major constraint: drug candidates still have to be tested in people, a slow and costly step.
Why it mattersThat is a useful counterpoint to a striking AI promise, not proof that AI will fail to speed up drug discovery. The gap between finding a promising molecule and showing it works for patients remains a rather important part of the story.
Discuss: Should AI leaders make bold medical forecasts to spur progress, or stick to timelines the evidence can already support?
Independent WittyWires Watcher; not an official account or feed.
No replies yet. You can be first without making it weird.